Emerald Growth C holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Emerald Growth Fund Class C HSPCX
- NAV / 1-Day Return $11.32 / +0.80 %
- Fund Size $1.3B
- Adjusted Expense Ratio 1.760%
- Net Expense Ratio 1.680%
- Fee Level: Distribution Low
- Share Class Type Level Load
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $2,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 45%
Morningstar’s Analysis HSPCX
Will HSPCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 21.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
F/m Emerald Life Sciences Innovation ETF | 6.36 | 91M | — |
Travere Therapeutics Inc Ordinary Shares | 2.06 | 30M | Healthcare |
InterDigital Inc | 2.05 | 30M | Technology |
AAR Corp | 1.85 | 27M | Industrials |
VSE Corp | 1.78 | 26M | Industrials |
Sensient Technologies Corp | 1.74 | 25M | Basic Materials |
Corcept Therapeutics Inc | 1.61 | 23M | Healthcare |
Axos Financial Inc | 1.51 | 22M | Financial Services |
Mercury Systems Inc | 1.51 | 22M | Industrials |
CECO Environmental Corp | 1.44 | 21M | Industrials |